H5P fundamentals
An in-depth look to HIKMA PHARMACEUTICALS PLC operating, investing, and financing activities
H5P free cash flow for H2 23 is 239.65 M EUR. For 2023, H5P free cash flow was 337.73 M EUR and operating cash flow was 494.54 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM